Monday, 25 March 2013

Expiry week in March

Ranbaxy and DLF had gone up. Worth holding still.
Ranbaxy consent decree outcome expected today, which will take stock up by 25/50 points up if issue is resolved if not this falling market will take it to 410/405 tomorrow. Since broad market is going down Ranbaxy very soon can go to 390 if there is any negative news from FDA.
Set limit of Rs. 12 to gain quick gain. If it goes below 408 in cash it will go below 400 within very short time.
But this is purely news based and let us understand everything is based on FDA's action.

DLF looks difficult now to go below 220 before expiry.

Today there was bounce due to short covering, but basic trend is negative. Market may open gap down tomorrow and it is better to set limit for options to gain profit.

This is time for long term buying, Good stocks like LT, SBI, TCS, Infy, TATAMOTORS should be accumulated with at least one year view. Please note, FII did huge buying in cash. They sold in future though. If this continues then market may again see rally upward very soon. This is extremely oversold market. Last week normally driven by option table and PCR is less than 0.8. This is really very bearish. This is difficult to sustain at this level and should soon find support.

Disclaimer: This blog does not take any responsibility of your profit/loss



No comments:

Post a Comment